This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_LIVER_INTRAHEPATIC_BILE_DUCTS_EXALLC for full statistics.
Malignant neoplasm of liver and intrahepatic bile ducts
C3_LIVER_INTRAHEPATIC_BILE_DUCTS
liver neoplasm: A benign or malignant epithelial neoplasm that affects the liver parenchyma and intrahepatic bile ducts. Representative examples of benign epithelial neoplasms include hepatocellular adenoma and intrahepatic bile duct adenoma. Representative examples of malignant epithelial neoplasms include hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Endpoint definition
↥
FinnGen phenotype data
392423 individuals
Apply sex-specific rule None
392423
Check conditions None
392423
Check pre-conditions, main-only, mode, registry filters
Cause of death: ICD-10
C22
Cause of death: ICD-9
155
Cause of death: ICD-8
155
Cancer registry: Topography ICD-O-3
C22
Cancer registry: Morphology ICD-O-3
ANY
Cancer registry: Behaviour codes
3
2 out of 7 registries used, show all original rules.
792
Check minimum number of events None
792
Include endpoints None
792
Remove individuals based on genotype QC
757
C3_LIVER_INTRAHEPATIC_BILE_DUCTS
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF9
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of liver and intrahepatic bile ducts
based on the number of shared cases.
Broader endpoints:
- Malignant neoplasm of liver and intrahepatic bile ducts (controls excluding all cancers)
- Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder (controls excluding all cancers)
- Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder
- Malignant neoplasm of digestive organs
- Malignant neoplasm of digestive organs (controls excluding all cancers)
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 757 | 138 | 619 |
| Unadjusted prevalence (%) | 0.20 | 0.07 | 0.37 |
| Mean age at first event (years) | 71.36 | 69.10 | 71.87 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: C3_LIVER_INTRAHEPATIC_BILE_DUCTS – Malignant neoplasm of liver and intrahepatic bile ducts
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Malignant neoplasm of liver and intrahepatic bile ducts
↥Endpoint not on priority list, no data to show.